With a market cap of $210.8 billion, Intuitive Surgical, Inc. (ISRG) designs, manufactures, and markets advanced ...

伦敦 - 专注于微创手术内窥镜的Creo Medical Group plc (AIM: CREO)公布了截至2024年12月31日的财年业绩。尽管略有波动，公司收入保持稳定，达到3040万英镑，与上年的3080万英镑基本持平。

Boston Scientific BSX is gaining from new product launches and accretive acquisitions. Yet, unfavorable currency movement and ...

The specialist has been performing robot-assisted operations since 2010, consolidating himself as one of the top experts in ...

(see more details here). Microbot Medical Inc (NASDAQ:MBOT) is a pre-commercial medical company that focuses on robotic endoluminal surgical systems for minimally invasive procedures. It has a ...

(see more details here). Close-up of a robotic endoluminal surgery device performing a procedure in an operating room. Microbot Medical Inc (NASDAQ:MBOT) is a pre-commercial medical company that ...

Cagent Vascular stated that the Serranator and Serranator SL-Pro PTA serration balloon catheters, which are FDA cleared, use the company’s stainless steel microserration technology that is designed to ...

Its products include the Ion Endoluminal and the Da Vinci Surgical systems. The company’s stock is surging, having grown around 60% over the past 12 months. Its Q4 2024 results showed ...

Intuitive Surgical, with its Da Vinci robots, enjoys a great competitive position in minimally invasive surgery, driven by $6 billion in R&D and first-mover advantage. The business model, with 84% ...